与PD-L1相关的IncRNA与质瘤中的恶性特征和免疫微环境有关
Zhiwei Xia1, Ruxin Tu2,3, Fangkun Liu4
1Department of Neurology, Hunan Aerospace Hospital, Changsha 410205, Hunan, P.R. China.
Aging
|October 14, 2023
概括
这项研究确定了六种与PD-L1相关的长非编码RNA (lncRNAs),可预测质瘤恶性和免疫治疗反应. 高LINC01271表达表明预后不佳和瘤攻击性增加.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 长非编码RNAs (lncRNAs) 是癌症诊断和治疗的新兴生物标志物.
- 质瘤是一种常见的大脑瘤,在诊断和治疗方面存在复杂的挑战.
- 与PD-L1相关的lncRNAs在质瘤恶性特征和免疫微环境中的作用需要进一步研究.
研究的目的:
- 探索PD-L1相关 lncRNAs 在质瘤中的功能.
- 确定用于预测质瘤预后和免疫治疗反应的新生物标志物.
- 调查LINC01271在质瘤进展中的特定作用.
主要方法:
- 利用TCGA和CGGA数据库用于质瘤基因表达和临床数据.
- 通过相关性分析,Cox和LASSO回归识别了6个PD-L1相关的lncRNA.
- 建立了一个风险评分模型,并进行了体外实验来验证LINC01271的影响.
主要成果:
- 一个基于6个PD-L1相关的lncRNA的风险评分模型准确地反映了质瘤恶性和免疫治疗反应.
- 高LINC01271表达与更糟糕的预后相关,增加M1巨细胞的丰富性,以及较高的瘤恶性.
- 在体外研究证实LINC01271促进质瘤细胞的增殖和迁移.
结论:
- 开发的风险评分模型有效预测质瘤特征和预后.
- LINC01271作为一个独立的预后指标和潜在的治疗质瘤的目标.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


